EMEA-001154-PIP02-15
Key facts
| Invented name |
Recombinant human antithrombin
|
| Active substance |
Antithrombin alfa
|
| Therapeutic area |
Haematology-Hemostaseology
|
| Decision number |
P/0350/2016
|
| PIP number |
EMEA-001154-PIP02-15
|
| Pharmaceutical form(s) |
Powder for solution for infusion
|
| Condition(s) / indication(s) |
Treatment of antithrombin deficiency
|
| Route(s) of administration |
Intravenous use
|
| Contact for public enquiries |
GTC Biotherapeutics UK Limited
|
| Decision type |
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
|